Eiko Lifesciences Ltd Stock Price Today (NSE: EIKO)
Fundamental Score
Eiko Lifesciences Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Eiko Lifesciences Ltd share price today is ₹44.16, up +0.66% on NSE/BSE as of 18 September 2026. Eiko Lifesciences Ltd (EIKO) is a Small-cap company in the Specialty Chemicals sector with a market capitalisation of ₹63.35 (Cr). The 52-week high for EIKO share price is ₹64.44 and the 52-week low is ₹43.00. At a P/E ratio of 17.00x, EIKO is currently trading below its industry average P/E of 31.95x. The company has a Return on Equity (ROE) of 5.70% and a debt-to-equity ratio of 0.07.
Eiko Lifesciences Ltd Share Price Chart — NSE/BSE Historical Performance
Eiko Lifesciences Ltd share price chart: -3.19% return over the past month. 52-week high ₹64.44, 52-week low ₹43.00.
Eiko Lifesciences Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹44.16 | ₹44.60 | ₹43.98 | ₹44.16 | 1.45K (Cr) | |
| ₹44.35 | ₹44.49 | ₹43.50 | ₹43.87 | 3.90K (Cr) | |
| ₹44.16 | ₹44.78 | ₹43.00 | ₹44.35 | 6.28K (Cr) | |
| ₹45.51 | ₹45.85 | ₹43.00 | ₹44.26 | 10.20K (Cr) | |
| ₹45.66 | ₹46.35 | ₹44.80 | ₹45.63 | 27.22K (Cr) | |
| ₹45.66 | ₹46.39 | ₹45.58 | ₹45.90 | 6.80K (Cr) | |
| ₹47.59 | ₹48.00 | ₹46.00 | ₹46.22 | 2.66K (Cr) | |
| ₹45.51 | ₹48.29 | ₹45.01 | ₹47.59 | 6.39K (Cr) | |
| ₹46.39 | ₹46.39 | ₹45.40 | ₹45.51 | 6.01K (Cr) | |
| ₹47.30 | ₹47.30 | ₹44.82 | ₹45.38 | 12.89K (Cr) |
Eiko Lifesciences Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹47.98 | ₹48.29 | ₹43.00 | ₹44.16 | -7.96% | |
| ₹49.18 | ₹50.96 | ₹44.75 | ₹47.04 | -4.35% | |
| ₹50.44 | ₹51.58 | ₹47.99 | ₹48.43 | -3.98% | |
| ₹53.44 | ₹57.50 | ₹48.58 | ₹50.44 | -5.61% | |
| ₹50.46 | ₹56.35 | ₹48.00 | ₹52.15 | +3.35% | |
| ₹50.98 | ₹55.00 | ₹49.00 | ₹50.46 | -1.02% | |
| ₹52.50 | ₹55.88 | ₹45.90 | ₹49.74 | -5.26% | |
| ₹54.66 | ₹54.66 | ₹49.00 | ₹51.46 | -5.85% | |
| ₹54.00 | ₹55.98 | ₹48.02 | ₹53.90 | -0.19% | |
| ₹52.30 | ₹59.00 | ₹48.00 | ₹55.05 | +5.26% | |
| ₹58.00 | ₹64.44 | ₹50.00 | ₹52.14 | -10.10% | |
| ₹53.25 | ₹57.99 | ₹49.86 | ₹56.35 | +5.82% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Eiko Lifesciences Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Eiko Lifesciences Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of EIKO across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Attractive Valuation (P/E: 17.00 vs Industry: 31.95)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Strong Revenue Growth (32.38%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Conservative Debt Levels (D/E: 0.07)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (22.59x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Healthy Liquidity Position (Current Ratio: 5.25)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Below-Average Return on Equity (5.70%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Eiko Lifesciences Ltd vs Specialty Chemicals Peers
Peer Comparison - Specialty Chemicals
Compare Eiko Lifesciences Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Eiko Lifesciences LtdEiko Lifescienc...Selected✓ EIKO • 540204 | 35.5/100 | ₹44.16₹44 | ₹63.35₹63.35 | 17.00Average 17.0 Average | 5.70%Poor 5.70% Poor | 11.13%Average 11.13% Average | 0.07Excellent 0.1 Excellent | — — | — — | 0.00% |
Pidilite Industries LimitedPidilite Indust... PIDILITIND • 500331 | 65.3/100 | ₹1572.00₹1572 | ₹159998.16₹159998.16 | 60.42Average 60.4 Average | 23.79%Excellent 23.79% Excellent | 29.92%Excellent 29.92% Excellent | 0.01Excellent 0.0 Excellent | 16.70%Excellent 16.70% Excellent | 14.89%Good 14.89% Good | 0.73% |
Gujarat Fluorochemicals LimitedGujarat Fluoroc... FLUOROCHEM • 542812 | 42.9/100 | ₹4755.00₹4755 | ₹52305.00₹52305.00 | 85.38Average 85.4 Average | 7.65%Poor 7.65% Poor | 10.87%Average 10.87% Average | 0.28Excellent 0.3 Excellent | 36.34%Excellent 36.34% Excellent | 13.52%Good 13.52% Good | 0.07% |
Navin Fluorine International LimitedNavin Fluorine ... NAVINFLUOR • 532504 | 62.7/100 | ₹8775.50₹8776 | ₹45018.32₹45018.32 | 56.92Average 56.9 Average | 20.11%Excellent 20.11% Excellent | 21.48%Excellent 21.48% Excellent | 0.31Excellent 0.3 Excellent | 20.84%Excellent 20.84% Excellent | 22.95%Excellent 22.95% Excellent | 0.20% |
Deepak Nitrite LimitedDeepak Nitrite ... DEEPAKNTR • 506401 | 32.8/100 | ₹1641.20₹1641 | ₹22385.97₹22385.97 | 28.57Average 28.6 Average | 9.81%Poor 9.81% Poor | 11.31%Average 11.31% Average | 0.26Excellent 0.3 Excellent | -6.63%Poor -6.63% Poor | 12.59%Good 12.59% Good | 0.44% |
Aether Industries LimitedAether Industri... AETHER • 543534 | 36.3/100 | ₹1615.50₹1616 | ₹21439.79₹21439.79 | 90.91Average 90.9 Average | 9.38%Poor 9.38% Poor | 12.78%Average 12.78% Average | 0.18Excellent 0.2 Excellent | — — | — — | 0.00% |
Atul LimitedAtul Limited... ATUL • 500027 | 58.2/100 | ₹6240.00₹6240 | ₹18370.56₹18370.56 | 23.10Average 23.1 Average | 11.47%Average 11.47% Average | 14.24%Average 14.24% Average | 0.03Excellent 0.0 Excellent | 54.89%Excellent 54.89% Excellent | 10.95%Good 10.95% Good | 0.49% |
Aarti Industries LimitedAarti Industrie... AARTIIND • 524208 | 38.7/100 | ₹496.50₹497 | ₹18009.05₹18009.05 | 33.91Average 33.9 Average | 7.25%Poor 7.25% Poor | 8.86%Poor 8.86% Poor | 0.83Good 0.8 Good | -4.35%Poor -4.35% Poor | 12.96%Good 12.96% Good | 0.20% |
BASF India LimitedBASF India Limi... BASF • 500042 | 52.2/100 | ₹3748.50₹3749 | ₹16227.26₹16227.26 | 25.21Average 25.2 Average | 0.00%Poor 0.00% Poor | 14.04%Average 14.04% Average | 0.00Excellent 0.0 Excellent | 7.67%Good 7.67% Good | 9.35%Good 9.35% Good | 0.68% |
Fine Organic Industries LimitedFine Organic In... FINEORG • 541557 | 62.09999999999999/100 | ₹5169.50₹5170 | ₹15849.69₹15849.69 | 36.18Average 36.2 Average | 16.82%Good 16.82% Good | 21.91%Excellent 21.91% Excellent | 0.02Excellent 0.0 Excellent | 28.23%Excellent 28.23% Excellent | 15.86%Excellent 15.86% Excellent | 0.21% |
Anupam Rasayan India LimitedAnupam Rasayan ... ANURAS • 543275 | 33.3/100 | ₹1228.00₹1228 | ₹13980.53₹13980.53 | 79.84Average 79.8 Average | 5.50%Poor 5.50% Poor | 9.10%Poor 9.10% Poor | 0.54Good 0.5 Good | 19.33%Excellent 19.33% Excellent | 23.88%Excellent 23.88% Excellent | 0.06% |
Top Specialty Chemicals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Pidilite Industries Limited share price159998.16 Cr
- Gujarat Fluorochemicals Limited share price52305.00 Cr
- Navin Fluorine International Limited share price45018.32 Cr
- Deepak Nitrite Limited share price22385.97 Cr
- Aether Industries Limited share price21439.79 Cr
Eiko Lifesciences Ltd PE Ratio History
Historical price-to-earnings ratio for EIKO — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹1.62 | ₹55.05 | 34x |
| FY 2024 | ₹0.73 | ₹62.74 | 85.9x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Eiko Lifesciences Ltd Quarterly Performance
Latest quarterly metrics for EIKO — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
32.38%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
15.95%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Eiko Lifesciences Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for EIKO — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Eiko Lifesciences Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Eiko Lifesciences Ltd (EIKO) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Eiko Lifesciences Ltd
About EIKO (Eiko Lifesciences Ltd)
Eiko Lifesciences Ltd is a dynamic force in the specialty chemicals arena, meticulously crafting high-value ingredients and solutions for diverse global industries. Focused on prec...ision and innovation, EIKO leverages cutting-edge research and development to synthesize complex molecules, catering to niche applications where quality and performance are paramount. From specialized agrochemical components that enhance crop yields to advanced pharmaceutical intermediates that accelerate drug discovery, EIKO's comprehensive portfolio is designed to meet the evolving needs of its discerning clientele. The company prides itself on its commitment to sustainable practices, employing green chemistry principles to minimize environmental impact throughout its manufacturing processes. EIKO's strategic divisions synergistically operate, contributing to a robust and vertically integrated business model. The agrochemical division develops novel chemistries for crop protection, while the pharmaceutical arm synthesizes critical intermediates for drug formulations. EIKO's foray into oleo chemicals allows the company to offer bio-based solutions derived from natural oils and fats. In food additives, the organization is actively in manufacturing high-quality ingredients to boost and improve food production. Moreover, the company's dedication extends beyond production, encompassing comprehensive services such as research, development, logistics, and efficient distribution channels. This holistic approach ensures seamless delivery of tailored solutions to clients across geographical boundaries. Driven by a customer-centric philosophy, EIKO invests heavily in building strong, collaborative partnerships. The company's team of experienced chemists and engineers works closely with clients, providing technical support, customized formulations, and reliable supply chain management. EIKO's commitment to quality is unwavering, adhering to stringent regulatory standards and employing rigorous quality control measures at every stage of production. Through continuous innovation, operational excellence, and a steadfast dedication to customer satisfaction, EIKO is poised to further solidify its position as a trusted and reliable provider of specialty chemicals worldwide.
Company Details
Key Leadership
EIKO Share Price: Frequently Asked Questions
What is the current share price of Eiko Lifesciences Ltd?
Eiko Lifesciences Ltd (EIKO) trades at ₹44.16 on NSE and BSE. Market cap ₹63.35 (Cr). Educational data only.
What is the P/E ratio of Eiko Lifesciences Ltd?
Eiko Lifesciences Ltd has a P/E of 17.00x vs industry average 31.95x.
What is the Bull Run score for Eiko Lifesciences Ltd?
Eiko Lifesciences Ltd has a Bull Run score of 35.5/100 based on 25+ financial parameters.
Does Eiko Lifesciences Ltd pay dividends?
Eiko Lifesciences Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Eiko Lifesciences Ltd?
Eiko Lifesciences Ltd has ROE of 5.70%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Eiko Lifesciences Ltd?
Eiko Lifesciences Ltd has debt-to-equity of 0.07.
Is Eiko Lifesciences Ltd a good investment?
Bull Run gives Eiko Lifesciences Ltd a score of 35.5/100. This is not investment advice — consult a SEBI-registered advisor.